A bill to direct the National Institute of Arthritis, Metabolism, and Digestive Diseases to conduct such studies as may be necessary to determine the safety and efficacy under section 505 of the Federal Food, Drug, and Cosmetic Act of dimethylsulfoxide (DMSO) as a topical analgesic and to provide that, if the drug is so determined to be safe and effective, new drug applications may be approved under such section based on the evidence submitted by the Institute.

Summary

Requires the Director of the National Institute of Arthritis, Metabolism, and Digestive Diseases to conduct such studies as are necessary to determine the safety and efficacy of dimethyl sulfoxide as a topical analgesic. Requires the submission and approval by the Secretary of Health and Human Services of a new drug application should such investigations prove the safety and efficacy of such substance for its intended use.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Introduced in House

  summary · EN · 26 June 1980

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.